+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury



Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury



Clinical Biochemistry 50(18): 1034-1039



Some blood biomarkers or histological examination by liver biopsy are used for the diagnosis of liver diseases in clinics. However, conventional blood biomarkers show poor specificity and sensitivity, and liver biopsy is highly invasiveness. Therefore, to overcome such disadvantages, specific/sensitive and noninvasive options are desirable. In recent years, circulating microRNAs (miRNAs) have been acknowledged for their potential as disease markers. Actually, several miRNAs have been reported to be biomarker candidates of liver diseases. However, these earlier studies were performed for one disease. Therefore, the specificity as biomarkers was not guaranteed, because they didn't study for the other types of liver injury. In this study, we examined if circulating miRNA could distinguish different types of liver diseases. Serum miRNA profiles in 28 patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis or drug-induced liver injury as well as 4 control subjects were determined by TaqMan MicroRNA Array analysis. Principal component analysis (PCA) of selected miRNAs was performed. We identified 37 miRNAs whose levels were significantly different between any of the groups. Although individual miRNAs could not distinguish different types of liver diseases, probably because of similar liver pathology, their profiling by PCA could classify different liver disease groups. The profiling of the selected miRNAs can be useful to distinguish different types of liver diseases.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060240602

Download citation: RISBibTeXText

PMID: 28823616

DOI: 10.1016/j.clinbiochem.2017.08.010


Related references

Intrahepatic status of regulatory T cells in autoimmune hepatitis, primary biliary cirrhosis, chronic hepatitis C, and chronic hepatitis B. 2007

Detection of antibodies to hepatitis E virus in patients with autoimmune chronic active hepatitis and primary biliary cirrhosis. Scandinavian Journal of Gastroenterology 32(4): 387-389, 1997

Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. Liver International 26(5): 559-565, 2006

Prevalence of antibodies against hepatitis C virus in primary biliary cirrhosis and autoimmune chronic hepatitis. Archives of Virology. Supplementum 4: 210-211, 1992

The prevalence of the hepatitis C antiviral antibody in primary biliary cirrhosis and chronic autoimmune hepatitis. Medicina Clinica 99(2): 77, 1992

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome in a patient with chronic hepatitis B infection. Gastroenterologia Y Hepatologia 36(6): 382-387, 2014

Serum-hepatitis antigen in chronic hepatitis and primary biliary cirrhosis. Lancet 1(7691): 159-161, 1971

Estimating survival in patients with primary biliary cirrhosis primary sclerosing cholangitis and autoimmune chronic active hepatitis application to liver transplantation. Hepatology 5(5): 1020, 1985

Cellular and humoral immune reactions in chronic active liver disease 1. lymphocyte subsets in liver biopsies of patients with untreated idiopathic auto immune hepatitis chronic active hepatitis b and primary biliary cirrhosis. Clinical and Experimental Immunology 50(1): 17-24, 1982

Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B cirrhosis before and after liver transplantation. Journal of Hepatology 28(Suppl. 1): 107, 1998

Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation. Liver 19(3): 177-182, 1999

Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis. Journal of Medicine 9(2): 117-128, 1978

Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients. Glycoconjugate Journal 33(2): 209-218, 2016

Living donor liver transplantation for autoimmune hepatitis and autoimmune hepatitis-primary biliary cirrhosis overlap syndrome. 2012

"Overlap" syndromes. Autoimmune hepatitis--primary biliary liver cirrhosis; autoimmune hepatitis--primary sclerosing cholangitis. Presse Medicale 30(1): 25-27, 2001